LATEST PODCAST:
Escape the Scale-Up Trap - Redefining Manufacturing Strategies
Listen now!
About Us
Our Company
Executive Leadership
Locations
Global Facilities Network
Seattle
Copenhagen
Heidelberg
Milan
Chiba
Our Services
Offerings
Mammalian
Microbial
pDNA
Viral Vectors
Cell Therapy
mRNA
Specialized Platforms & Programs
AGCellerate™
BravoAAV™
ProntoLVV™
Proveo™
CMC Jumpstart™
Services
Tech Transfer
Process Development
Cell Line Development
Analytical & Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
Fill & Finish
News & Resources
News & Blogs
Press Releases
Biopharma Thought Leadership Blog
Events & Conferences
Resources
Resources & Scientific Content
Fact Sheets
Case Studies
Video Library
Media Kit
Careers
Career Opportunities
Life at a CDMO
Diversity, Equity & Inclusion
Seattle Team
Copenhagen Team
Heidelberg Team
Milan Team
Chiba Team
Yokohama Team
Search
Search
Toggle Menu
Search
Search
Toggle Menu
About Us
Toggle Menu
Our Company
Executive Leadership
Locations
Toggle Menu
Global Facilities Network
Seattle
Copenhagen
Heidelberg
Milan
Chiba
Our Services
Toggle Menu
Offerings
Toggle Menu
Mammalian
Microbial
pDNA
Viral Vectors
Cell Therapy
mRNA
Specialized Platforms & Programs
Toggle Menu
AGCellerate™
BravoAAV™
ProntoLVV™
Proveo™
CMC Jumpstart™
Services
Toggle Menu
Tech Transfer
Process Development
Cell Line Development
Analytical & Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
Fill & Finish
News & Resources
Toggle Menu
News & Blogs
Toggle Menu
Press Releases
Biopharma Thought Leadership Blog
Events & Conferences
Resources
Toggle Menu
Resources & Scientific Content
Fact Sheets
Case Studies
Video Library
Media Kit
Careers
Toggle Menu
Career Opportunities
Life at a CDMO
Diversity, Equity & Inclusion
Seattle Team
Copenhagen Team
Heidelberg Team
Milan Team
Chiba Team
Yokohama Team
Our Company
About Us
Our History
Mission & Values
Executive Leadership
Locations
Global Facilities Network
Seattle
Copenhagen
Heidelberg
Milan
Chiba
Yokohama
Policies
Environment, Health & Safety
Group Privacy Policies
Offerings
Mammalian
Microbial
pDNA
Viral Vectors
Cell Therapy
mRNA
Services
Tech Transfer
Process Development
Cell Line Development
Analytical & Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
Fill & Finish Services
Specialized Platforms & Programs
AGCellerate™ mAb & LVV Programs
ProntoLVV™ Lentiviral Vector Platform
BravoAAV™ Adeno-Associated Vector Platform
Proveo™ ADC Program
CMC Jumpstart™ Program
News & Blogs
Press Releases
Biopharma Thought Leadership Blog
Events & Conferences
Resources
Research & Scientific Content
Fact Sheets
Case Studies
Video Library
Media Kit
Fact Sheet Quick Links
Global cGMP Manufacturing (PDF)
Mammalian Capabilities (PDF)
Microbial Capabilities (PDF)
Cell Therapy Capabilities (PDF)
Viral Vector Capabilities (PDF)
Plasmid DNA Capabilities (PDF)
Messenger RNA Capabilities (PDF)
Join Us
Career Opportunities
What Drives Us
Life at a CDMO
Diversity, Equity and Inclusion
Meet Our Teams
Seattle
Copenhagen
Heidelberg
Milan
Chiba
Yokohama
AGC Biologics Plasmid Production
AGC Biologics
March 16, 2020 at 1:58 PM
Press Release
Tweet
Flen Health Chooses AGC Biologics to Manufacture Recombinant Enzymes for Next-Generation Wound Treatment
September 24, 2026 at 12:00 AM
Press Release
Tech Transfer
Microbial
AGC Biologics Lands Commercial Manufacturing Agreement for Yokohama Site Worth Hundreds of Millions of Dollars
July 28, 2026 at 6:00 AM
Mammalian & mAbs
Press Release
Business Updates
AGC Biologics Expands to Fill-Finish in U.S. Through Strategic Partnership with Pyramid Pharma Services
June 30, 2026 at 9:00 AM
Mammalian & mAbs
Press Release
Business Updates
Microbial
